ERVW-1 and infection: It may be necessary for a successful vaccine regimen to replicate the chronic exposure experienced in natural infection during which somatic mutation of Env-specific antibodies may lead to their increased neutralizing capacity [17], [58], potentially resulting in NAbs of great potency and breadth [20], [26], [39].